Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01305486 · ClinicalTrials.gov registry record
A Study of Complex Ventral Hernia Repair Utilizing the XenMatrix™ Surgical Graft With Component Separation
A clinical trial, sponsored by C. R. Bard.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01305486: Clinical Trial study, sponsored by C. R. Bard.
NCT01305486 is a clinical trial that was terminated before completion, run by C. R. Bard. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01305486 was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This will be an observational study designed to collect early, short- and long-term clinical outcomes of the XenMatrix™ Surgical Graft for complex ventral hernia repair. Subjects will be expected to attend follow up visits at 1, 6, 12, 18 and 24 months following surgery.
Primary Outcome
Any hernia which is identified or confirmed by the investigator in approximately the same position as the hernia repair during any follow up visit after a XenMatrix™ surgical graft has been placed will be considered a recurrent hernia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-06 |
Why NCT01305486 stopped before completion
NCT01305486 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01305486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01305486 about?
NCT01305486 is a clinical study titled "A Study of Complex Ventral Hernia Repair Utilizing the XenMatrix™ Surgical Graft With Component Separation". This will be an observational study designed to collect early, short- and long-term clinical outcomes of the XenMatrix™ Surgical Graft for complex ventral hernia repair. Subjects will be expected to attend follow up visits at 1, 6, 12, 18 and 24 months following surgery.
What is the current status of trial NCT01305486?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2010-09. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT01305486?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia